These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8793694)

  • 41. Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis.
    Kiss Z; Ambrus C; Kulcsár I; Szegedi J; Kiss I; ;
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1021-7. PubMed ID: 25002133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians.
    Foy CA; McCormack LJ; Knowler WC; Barrett JH; Catto A; Grant PJ
    J Med Genet; 1996 Apr; 33(4):336-7. PubMed ID: 8730292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
    Velloso EP; Vieira R; Cabral AC; Kalapothakis E; Santos RA
    Braz J Med Biol Res; 2007 Apr; 40(4):583-90. PubMed ID: 17401503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease.
    Taute BM; Handschug K; Taute R; Seifert H; Gläser C; Podhaisky H
    Vasa; 1998 Aug; 27(3):149-53. PubMed ID: 9747149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.
    Cambien F; Costerousse O; Tiret L; Poirier O; Lecerf L; Gonzales MF; Evans A; Arveiler D; Cambou JP; Luc G
    Circulation; 1994 Aug; 90(2):669-76. PubMed ID: 8044936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism.
    Almeida SS; Barros CC; Moraes MR; Russo FJ; Haro AS; Rosa TS; Alves MF; Pesquero JB; Carmona AK; Bacurau RF; Araújo RC
    Neuropeptides; 2010 Apr; 44(2):139-43. PubMed ID: 20064660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indirect Back-Titration ELISA: A New Format for Estimation of Human Tissue Kallikreins.
    Nasim FU; Ejaz S; Ashraf M; Ahmad G
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):64-70. PubMed ID: 26180936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyl-leucine as substrate.
    Jalil JE; Ocaranza MP; Piddo AM; Jalil R
    J Lab Clin Med; 1999 May; 133(5):501-6. PubMed ID: 10235133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans.
    Jalil JE; Ocaranza MP; Oliveri C; Córdova S; Godoy I; Chamorro G; Braun S; Fardella C; Michel JB; Lavandero S
    J Hum Hypertens; 2004 Feb; 18(2):119-25. PubMed ID: 14730327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC.
    Oruç N; Lamb J; Whitcomb DJ; Sass DA
    Turk J Gastroenterol; 2008 Dec; 19(4):250-3. PubMed ID: 19119484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification of radiolabeled monoclonal antibodies to angiotensin-converting enzyme significantly improves specificity and efficacy of its targeting into the lung.
    Hiemisch H; Gavrilyuk V; Atochina E; Slinkin M; Torchilin V; Muzykantov V; Danilov S
    Nucl Med Biol; 1993 May; 20(4):435-41. PubMed ID: 8389221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of two solid-phase enzyme immunoassays (ELISA) for quantitation of human epidermal growth factors (hEGFs).
    Sizemore N; Dudeck RC; Barksdale CM; Nordblom GD; Mueller WT; McConnell P; Wright DS; Guglietta A; Kuo BS
    Pharm Res; 1996 Jul; 13(7):1088-94. PubMed ID: 8842051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients.
    Oh TG; Shin CS; Park KS; Kim SY; Cho BY; Lee HK; Koh CS
    Korean J Intern Med; 1996 Jun; 11(2):133-7. PubMed ID: 8854649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies 1B3 and 5C8 as probes for monitoring the integrity of the C-terminal end of soluble angiotensin-converting enzyme.
    Balyasnikova IV; Sun ZL; Franke FE; Berestetskaya YV; Chubb AJ; Albrecht RF; Sturrock ED; Danilov SM
    Hybridoma (Larchmt); 2005 Feb; 24(1):14-26. PubMed ID: 15785205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy.
    Lee JM; Lo AC; Yang SY; Tsau HS; Chen RJ; Lee YC
    Ann Surg; 2005 Apr; 241(4):659-65. PubMed ID: 15798469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.